Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://kallumeypk723891.educationalimpactblog.com/60375940/semaglutide-a-potential-solution-for-metabolic-disorders